2022 the Japanese Society of Medical Oncology Annual Meeting

Session information

Poster Session

[P78] Poster Session 78 Translational Research/Clinical Pharmacology(Pharmacology)

Hiroo Ishida1, Yuta Nio2, Natsumi Matsumoto2, Sojiro Kusumoto3, Yutaro Kubota4, Takuya Tsunoda4, Yasutsuna Sasaki4, Ken-Ichi Fujita2 (1.Department of Medical Oncology, Showa University Northern Yokohama Hospital, 2.Division of Cancer Genome and Pharmacotherapy, Department of Clinical Pharmacy, Showa University School of Pharmacy, 3.Division of Respiratory Medicine and Allergology, Department of Medicine, Showa University School of Medicine, 4.Division of Medical Oncology, Department of Medicine, Showa University School of Medicine)

Makoto Maeda1, Daisuke Amenomiya1, Reiko Ando Makihara1, Naomi Sakiyama1, Yoshinori Makino2, Eishi Imoto3, Daisuke Kawakami3, Ken Masuda4, Yuki Shinno4, Yusuke Okuma4, Tatsuya Yoshida4, Yasushi Goto4, Hidehito Horinouchi4, Mitsunobu Ishikawa1, Yoshimasa Saito1, Toru Akagi1, Hironobu Hashimoto4, Noboru Yamamoto4, Yuichiro Ohe4, Tetsuya Furukawa1 (1.Department of Pharmacy, National Cancer Center Hospital, 2.Department of Cancer Genome Medicine, Department of Pharmacy, Saitama Medical University International Medical Center, 3.SHIMADZU CORPORATION, 4.Department of Thoracic Oncology, National Cancer Center Hospital)

Takuro Saiki1, Genki Ogata2,3, Seishiro Sawamura2, Olga Razvina4, Kota Watanabe4, Rito Kato4, Yoshifumi Matsumoto1, Masato Moriyama1, Hiroyuki Kusuhara5, Yasuaki Einaga3, Yasuo Saijo1, Hiroshi Hibino2 (1.Department of Medical Oncology, Niigata University, 2.Division of Glocal Pharmacology, Department of Pharmacology, Osaka University, 3.Department of Chemistry, Keio University, 4.School of Medicine, Niigata University, 5.Graduate School of Pharmaceutical Sciences, The University of Tokyo)